Molecular cancer therapy: can our expectation be MET?

C Migliore, S Giordano - European Journal of Cancer, 2008 - Elsevier
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

[引用][C] Molecular cancer therapy: Can our expectation be MET?

C MIGLIORE, S GIORDANO - European journal of cancer …, 2008 - pascal-francis.inist.fr
Molecular cancer therapy : Can our expectation be MET? CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Molecular cancer therapy: can our expectation be MET?

C Migliore, S Giordano - … Journal of Cancer (Oxford, England: 1990), 2008 - europepmc.org
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

Molecular cancer therapy: can our expectation be MET?

C Migliore, S Giordano - European journal of cancer …, 2008 - pubmed.ncbi.nlm.nih.gov
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

Molecular cancer therapy: Can our expectation be MET?

C Migliore, S Giordano - European Journal of Cancer, 2008 - ejcancer.com
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

Molecular cancer therapy: can our expectation be met?

C Migliore, S Giordano - EUROPEAN JOURNAL OF CANCER, 2008 - iris.unito.it
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumors and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

Molecular cancer therapy: Can our expectation be MET?

C Migliore, S Giordano - European Journal of Cancer, 2008 - infona.pl
Altered regulation of tyrosine kinase receptors (RTKs) is frequent in solid tumours and it is
often associated with the acquisition of an aggressive phenotype. Thus, therapies targeting …

[引用][C] Molecular cancer therapy: can our expectation be MET?

C MIGLIORE - Eur J Cancer, 2008 - cir.nii.ac.jp

[引用][C] Molecular cancer therapy: Can our expectation be MET?

C Migliore, S Giordano - European Journal of Cancer, 2008 - cir.nii.ac.jp
Molecular cancer therapy: Can our expectation be MET? | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …